歯科用バイオマテリアルの世界市場-2022-2029

市場力学

歯科疾患の有病率の増加、老年人口の増加、審美歯科に対する需要の増加、歯科・口腔ケアに対する支出の増加、新規接着剤、CAD/CAMにおけるレジンセメント、その他のデジタル技術の採用の増加などが市場を牽引しています。

口腔内疾患の増加は、市場成長の原動力になると予想されます。

歯周病、虫歯、口腔がん、う蝕、口臭などの口腔内疾患が市場成長の原動力となっています。米国疾病対策予防センター（CDC）によると、歯周病の兆候は30歳以上の全人口の46％に見られ、重篤な歯周病は成人の約9％が罹患しているとされています。また、未治療の虫歯は、米国では約26％の人が罹患していると言われています。さらに、国立歯科・頭蓋顔面研究所によると、20歳から64歳の成人の92％が永久歯に虫歯があり、平均重症度は3.28本の永久歯が虫歯になり、13.65本の永久歯が欠損しているとのことです。中低所得国での歯科インプラントの意義に対する認識が高まっていることが、予測期間を通じて市場の成長を促進すると考えられます。また、先進国における可処分所得の増加に伴い、歯のホワイトニングや歯肉の輪郭形成などの審美的な処置に対する需要も増加しています。したがって、上記の記述から、予測期間中に市場が牽引されることが予想されます。

抑制要因

治療費の高さ、厳しい規制や臨床プロセスの存在、保険による償還の低さが、予測期間中の市場を抑制します。

産業分析

歯科用バイオマテリアル市場は、アンメットニーズ、価格分析、サプライチェーン分析、規制分析など、様々な業界要因に基づく市場の詳細な分析を提供します。

目次

第1章 調査手法と調査範囲

• 調査手法
• 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

• 製品別市場内訳
• タイプ別市場内訳
• アプリケーション別市場内訳
• エンドユーザー別市場内訳
• 地域別市場内訳
• DataM CLOシナリオ

第4章 市場の力学

• 市場影響要因
  • 促進要因
    • 歯科疾患の有病率の増加
    • 高齢者人口の増加
    • 歯科医療費の増加
    • 技術的進歩
  • 抑制要因
    • 高い治療費
    • 厳しい規制と臨床プロセス
  • ビジネスチャンス
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 規制分析
• 疫学

第6章 製品別

• ボーングラフト材料
  • アロングラフト
  • ゼノグラフト
  • 合成樹脂製
• 歯科用メンブレン
• 軟組織再生材料
• その他（歯科用セメント、歯科用印象材）

第7章 タイプ別

• 金属系
• セラミック
• 天然歯科用バイオマテリアル

第8章 用途別

• インプラント分野
• 歯周病学
• 歯科補綴学
• 歯科矯正学
• その他

第9章 エンドユーザー別

• 歯科インプラント・歯科補綴メーカー
• 歯科技工所
• 歯科病院・歯科医院
• その他（歯科大学、研究機関など）

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他の南米地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ地域

第11章 競合情勢

• 競合シナリオ
• 競合の歯科用バイオマテリアル戦略分析
• 比較製品ポートフォリオ分析
• 市況/シェア分析
• M&A（合併・買収）分析

第12章 企業プロファイル

• Straumann AG
  • 企業概要
  • 製品ポートフォリオと説明
  • 主なハイライト
  • 財務概要
• Geistlich Pharma AG
• Zimmer Biomet Holdings, Inc.
• Danaher Corporation
• Dentsply Sirona, Inc.
• 3M Company
• Royal DSM
• Kuraray Co., Ltd
• Medtronic Plc.
• Henry Schein, Inc.
• Victrex Plc
• Ivoclar Vivadent AG
• BEGO Medical GmbH

第13章 DataM

Market Overview

The Dental Biomaterials Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 5.7% during the forecast period (2022-2029)

Dental biomaterials are specialized natural or synthetic products designed to be used in preventive and restorative dentistry. These products are used to restore damaged, decayed, or fractured teeth. Dental biomaterials are efficient products with a high success rate in oral treatment and prevention. These products replace the damaged or missing tooth tissues and also promote tissue regeneration. Natural biomaterials include enamel, dentin, cementum, bone, and other intraoral tissues and synthetic materials include metals, ceramics, polymers, and composite structures.

Market Dynamics

The market is driven by the growing prevalence of dental disorders, rising geriatric population, increasing demand for cosmetic dentistry, increase in expenditure on dental and oral care, and increasing adoption of novel adhesives, resin cement in CAD/CAM, and other digital technologies.

The increasing prevalence of oral disorders is expected to drive market growth.

Oral disorders such as periodontal disease, tooth decay, oral cancer, dental caries, and halitosis, among others, are driving the market growth. According to the Centers for Disease Control and Prevention (CDC), indications of gum disease are present in 46 percent of all persons aged 30 and older, with serious gum disease affecting approximately 9% of adults. Untreated dental decay affects approximately 26% of persons in the United States. Furthermore, according to the National Institute of Dental and Craniofacial Research, 92 percent of adults aged 20 to 64 have dental caries in their permanent teeth, with an average severity of 3.28 decayed or missing permanent teeth and 13.65 decaying and missing permanent teeth. Increased awareness of the significance of dental implants in middle and low-income nations will drive market growth throughout the forecast period. Aside from that, as disposable income in industrialized countries has increased, so has demand for aesthetic procedures like teeth whitening and gum contouring. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint:

High cost of treatment, presence of stringent regulatory and clinical processes, and low reimbursement coverage by insurance are going to restrain the market in the forecast period.

Industry Analysis

The dental biomaterials market provides in-depth analysis of the market based on various industry factors such as unmet needs, pricing analysis, supply chain analysis, regulatory analysis etc.

Segment Analysis

Polymeric Biomaterials segment is expected to hold the largest market share in the dental biomaterials market.

The polymeric biomaterials segment accounted for the largest market share in 2021. The segment benefits because of high product durability, reduced risks of infections compared to other materials, material flexibility that provides ease in shape formation, biocompatibility, good resilience, lightweight, easy fabrication, and high corrosion resistance. Moreover, polymeric biomaterials have unique antimicrobial and drug delivery properties in preventive, regenerative, and restorative therapies to reduce friction and corrosion in dentistry. Therefore, it has increased the demand for polymeric biomaterials. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North American region is expected to hold the largest market share in the global dental biomaterials market.

The North American region accounted for the largest market share in 2021. Owing to the increasing prevalence of caries and the presence of major players within the region, high dental expenditure within the Americas are the factors to drive the market growth. For instance, according to a recent paper by the American College of Prosthodontists, more than 36 million Americans are toothless, and 120 million have at least one missing tooth. Such circumstances in the Americas increase the demand for prosthodontics and implants. Moreover, Pulpdent Corporation, a dental research and manufacturing business in the Greater Boston area, launched ACTIVA Presto dental material in January 2020. The new white dental filling material has qualities similar to natural teeth. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the dental biomaterials market are Straumann AG, Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Danaher Corporation, Dentsply Sirona, Inc., 3M Company, Royal DSM, Kuraray Co., Ltd, Medtronic Plc., Henry Schein, Inc., Mitsui Chemicals, Inc., Victrex Plc, Ivoclar Vivadent AG, GC Corporation, Keystone Dental, Inc., Datum Dental Ltd, BEGO Medical GmbH, Cam Bioceramics B.V., Geistlich Pharma AG, BioHorizons IPH, Inc., and Biomatlante.

Straumann:

Straumann is a global leader in implant, restorative and regenerative dentistry. The company researches, develop, and manufacture dental implants, instruments, prosthetics, and tissue and bone regeneration biomaterials in collaboration with leading clinics, research institutes, and universities for tooth replacement and restoration or to prevent tooth loss. The company has six production sites for implants, biomaterials and CAD/CAM in Europe, the United States and Japan. Its extensive network of distribution subsidiaries and partners makes its products and services available in over 70 countries. The company's periodontal product portfolio includes Straumann Emdogain FL, leading to true periodontal regeneration based on biomimicry.

Product Portfolio:

Straumann XenoFlex: Straumann XenoFlex is a biomimetric composite material that resembles the native bone in its basic biphasic composition of collagen and xenogenic hydroxyapatite. It has beneficial handling characteristics and the ability to be shaped to match the individual defect situation. Straumann XenoFlex - an efficient, easy to handle, volume stable solution for the treatment of bone defects.

The global dental biomaterials market report would provide an access to an approx. 45+market data table, 40+figures

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

• 3.1. Market Snippet by Product
• 3.2. Market Snippet by Type
• 3.3. Market Snippet by Application
• 3.4. Market Snippet by End User
• 3.5. Market Snippet by Region
• 3.6. DataM CLO Scenario

4. Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Growing prevalence of dental disorders
    • 4.1.1.2. Rising geriatric population
    • 4.1.1.3. Increase in expenditure on dental
    • 4.1.1.4. Technological advancements
  • 4.1.2. Restraints
    • 4.1.2.1. High cost of treatment
    • 4.1.2.2. Stringent regulatory and clinical processes
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Regulatory Analysis
• 5.4. Epidemiology

6. By Product

• 6.1. Introduction
• 6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
• 6.3. Market Attractiveness Index, By Product
• 6.4. Bone Graft Materials*
  • 6.4.1. Introduction
  • 6.4.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 6.4.3. Allografts
  • 6.4.4. Xenografts
  • 6.4.5. Synthetic
• 6.5. Dental Membranes
• 6.6. Soft Tissue Regeneration Products
• 6.7. Others (dental cement, dental impression materials)

7. By Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  • 7.1.2. Market Attractiveness Index, By Type
• 7.2. Metallic
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
• 7.3. Ceramic
• 7.4. Natural Dental Biomaterials

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Implantology
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
• 8.3. Periodontology
• 8.4. Prosthodontics
• 8.5. Orthodontics
• 8.6. Others

9. By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 9.1.2. Market Attractiveness Index, By End User
• 9.2. Dental implant and prosthetic manufacturers
  • 9.4.1. Introduction
  • 9.4.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
• 9.3. Dental laboratories
• 9.4. Dental hospitals and clinics
• 9.5. Others (Dental academies and research institutes)

10. By Region

• 10.1. North America
  • 10.1.1. U.S.
  • 10.1.2. Canada
  • 10.1.3. Mexico
• 10.2. Europe
  • 10.2.1. Germany
  • 10.2.2. U.K.
  • 10.2.3. France
  • 10.2.4. Italy
  • 10.2.5. Spain
  • 10.2.6. Rest of Europe
• 10.3. South America
  • 10.3.1. Brazil
  • 10.3.2. Argentina
  • 10.3.3. Rest of South America
• 10.4. Asia Pacific
  • 10.4.1. China
  • 10.4.2. India
  • 10.4.3. Japan
  • 10.4.4. Australia
  • 10.4.5. Rest of Asia Pacific
• 10.5. Middle East and Africa

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Competitor Dental Biomaterials Strategy Analysis
• 11.3. Comparative Product Portfolio Analysis
• 11.4. Market Positioning/Share Analysis
• 11.5. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Straumann AG*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Key Highlights
  • 12.1.4. Financial Overview
• 12.2. Geistlich Pharma AG
• 12.3. Zimmer Biomet Holdings, Inc.
• 12.4. Danaher Corporation
• 12.5. Dentsply Sirona, Inc.
• 12.6. 3M Company
• 12.7. Royal DSM
• 12.8. Kuraray Co., Ltd
• 12.9. Medtronic Plc.
• 12.10. Henry Schein, Inc.
• 12.11. Victrex Plc
• 12.12. Ivoclar Vivadent AG
• 12.13. BEGO Medical GmbH

13. DataM Intelligence

• 13.1. Appendix
• 13.2. About Us and Services
• 13.3 Contact Us